Pharmaceutisch Weekblad

, Volume 7, Issue 5, pp 212–218 | Cite as

Ethnopharmacological table on some reputedly psychoactive fumigatories among Middle and South American natives

  • P. A. G. M. De Smet
Short Communications


Data on the ethnopharmacology of ritual fumigatories in Middle and South America are summarized in table format. A literature search has yielded twenty-two plant species belonging to fifteen different genera as established or suggested ingredients of ritual fumigatories among the natives in these regions. Seven species contain a psychoactive principle and may very well be effective when smoked, six species contain a psychoactive principle but their efficacy when smoked is uncertain, and nine plants have not been adequately proved to contain a psychoactive principle.


Public Health Internal Medicine Plant Species Literature Search American Native 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bruhn JG, Holmstedt B. Ethnopharmacology, Objectives, Principles and Perspectives. In: Beal JL, Reinhard E, eds. Natural Products as Medicinal Agents. Stuttgart: Hippokrates Verlag, 1981:405–30.Google Scholar
  2. 2.
    Buurma H, Vulto AG. Drugs used in nonorthodox medicine. In: Dukes MNG, ed. Side Effects of Drugs Annual 8. Amsterdam: Elsevier Science Publishers BV, 1984:441–7.Google Scholar
  3. 3.
    Xiao P-G. Traditional Experience of Chinese Herb Medicine, its Application in Drug Research and New Drug Searching. In: Beal JL, Reinhard E, eds. Natural Products as Medicinal Agents. Stuttgart: Hippokrates Verlag, 1981:351–94.Google Scholar
  4. 4.
    Jiang J-B, Li G-Q, Guo X-B, Kong YC, Arnold K. Antimalarial activity of mefloquine and qinghaosu. Lancet 1982;2:285–8.PubMedGoogle Scholar
  5. 5.
    Li G, Arnold K, Guo X, Jian H, Fu L. Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadioxine in patients with falciparum malaria. Lancet 1984:2:1360–1.PubMedGoogle Scholar
  6. 6.
    Krogsgaard-Larsen P, Brogger Christensen S, Kofod H, eds. Natural Products and Drug Development. Proceedings of the Alfred Benzon Symposium 20. Copenhagen: Munskgaard, 1984.Google Scholar
  7. 7.
    Spjut RW, Perdue Jr RE. Plant folklore: a tool for predicting sources of antitumor activity? Cancer Treat Rep 1976;60:979–85.PubMedGoogle Scholar
  8. 8.
    Hall RCW, Pfefferbaum B, Gardner ER, Stickney SK, Perl M. Intoxication with Angel's Trumpet: Anticholinergic Delirium and Hallucinosis. J Psychedelic Drugs 1978;10:251–3.Google Scholar
  9. 9.
    Young RE, Hutchinson S, Milroy R, Kesson CM. The rising price of mushrooms. Lancet 1982;1:213–5.PubMedGoogle Scholar
  10. 10.
    Falch E, Christensen V, Jacobsen P, Byberg J, Krogsgaard-Larsen P.Amanita muscaria in Medicinal Chemistry. 1. Muscimol and Related GABA Agonists with Anticonvulsant and Central Non-Opioid Analgesic Effects In: Krogsgaard-Larsen P, Brogger Christensen S, Kofod H. eds. Natural Products and Drug Development. Proceedings of the Alfred Benzon Symposium 20. Copenhagen: Munskgaard, 1984:504–22.Google Scholar
  11. 11.
    Grinspoon L, Bakalar JB. Psychedelic Drugs Reconsidered. New York: Basic Books, 1981.Google Scholar
  12. 12.
    Schultes RE, Hoffmann A. The Botany and Chemistry of Hallucinogens. 2nd ed. Springfield: Charles C. Thomas Publisher, 1980.Google Scholar
  13. 13.
    Rebuck AS, Braude AC. Assessment of Drug Disposition in the Lung. Drugs 1984;28:544–53.PubMedGoogle Scholar
  14. 14.
    Routledge PA, Shand DG. Presystemic drug elimination. Annu Rev Pharmacol Toxicol 1979;19:447–68.CrossRefPubMedGoogle Scholar
  15. 15.
    Janiger O, Dobkin de Rios M.Nicotiana a Hallucinogen? Econ Botany 1976;30:149–51.Google Scholar
  16. 16.
    Ohlsson A, Lindgren J-E, Wahlen A, Agurell S, Hollister LE, Gillespie HK. Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 1980;28:409–16.PubMedGoogle Scholar
  17. 17.
    Castaneda C. The Teachings of Don Juan: A Yaqui Way of Knowledge. Harmondsworth: Penguin Books, 1970.Google Scholar
  18. 18.
    Castaneda C. A Separate Reality — Further Conversations with Don Juan. New York: Pocket Books, 1972.Google Scholar
  19. 19.
    Siegel RK. Castanedas Privatapotheke. In: Völger G, Von Welck K, Legnaro A, eds. Rausch und Realität — Drogen im Kulturvergleich. Teil 2. Köln: Rautenstrauch-Joest-Museum für Völkerkunde, 1981:716–23.Google Scholar
  20. 20.
    De Mille R. Allegory is not Ethnobotany: Analyzing Castaneda's Letter to R. Gordon Wasson and Carlos's Spanish Fieldnotes. In: De Mille R, ed. The Don Juan Papers — Further Castaneda Controversies. Santa Barbara: Ross-Erikson Publishers, 1980:319–32.Google Scholar
  21. 21.
    Díaz JL. Ethnopharmacology and Taxonomy of Mexican Psychodysleptic Plants. J Psychedelic Drugs 1979;11:71–101.PubMedGoogle Scholar
  22. 22.
    De Smet PAGM. A multidisciplinary overview of intoxicating enema rituals in the western hemisphere. J Ethnopharmacol 1983:9:129–66.PubMedGoogle Scholar
  23. 23.
    Ott J. Psycho-Mycological Studies ofAmanita — from Ancient Sacrament to Modern Phobia. J Psychedelic Drugs 1976;8:27–35.Google Scholar
  24. 24.
    Dobrizhoffer M. An account of the Abipones, an equestrian people of Paraguay. Vol. 1 and 11. London: John Murray, 1822.Google Scholar
  25. 25.
    Califano M. El chamanismo mataco. Scripta Etnologica 1975;3(2):30–7.Google Scholar
  26. 26.
    Von Reis Altschul S. Vilca and its use. In: Efron DH, Holmstedt B, Kline NS, eds. Ethnopharmacological Search for Psychoactive Drugs. U.S. Department of Health, Education and Welfare, Publ. no. 1645. Washington: Government Printing Office, 1967:307–14.Google Scholar
  27. 27.
    Iacobucci GA, Rúveda EA. Bases derived from tryptamine in ArgentinePiptadenia species. Phytochemistry 1964;3:465–7.CrossRefGoogle Scholar
  28. 28.
    Brimblecombe RW, Pinder RM. Hallucinogenic agents. Bristol: Wright-Scientechnica, 1975.Google Scholar
  29. 29.
    Schomburgk R. Reisen in Britisch-Guiana in den Jahren 1840–1844. 11. Leipzig: J.J. Weber, 1848.Google Scholar
  30. 30.
    MacDougall T.Calea zacatechichi. A Composite with Psychic Properties? Garden J 1968;18:105.Google Scholar
  31. 31.
    Herz W, Kumar N. Sesquiterpene lactones ofCalea zacatechichi and C.urticifolia. Phytochemistry 1980:19:593–7.Google Scholar
  32. 12.
    Quijano L, Romo de Vivar A, Rios T. Revision of the structures of caleine A and B, germacranolide sesquiterpenes fromCalea zacatechichi. Phytochemistry 1979:18:1745–7.Google Scholar
  33. 33.
    Wagley C, Galvāo E. The Tenetehara Indians of Brazil. New York: Columbia University Press, 1949.Google Scholar
  34. 34.
    Heffern R. Secrets of the mind-altering plants of Mexico. New York: Pyramid Books, 1974.Google Scholar
  35. 35.
    Williams-Garcia R. The Ritual Use ofCannabis in Mexico. In: Rubin V, ed. Cannabis and Culture. The Hague: Mouton, 1975:133–45.Google Scholar
  36. 36.
    Turner CE, Elsohly MA, Boeren EG. Constituents ofCannabis sativa L. XVI: a review of the natural constituents. J Nat Prod 1980:43:169–234.CrossRefPubMedGoogle Scholar
  37. 37.
    Meyer R. The Acute Mental Effects of Marihuana. In: Van Praag HM, ed. Biochemical and Pharmacological Aspects of Dependence and Reports on Marihuana Research. Haarlem: De Erven F. Bohn, 1972:144–59.Google Scholar
  38. 38.
    Barnett G, Chiang C-WN, Perez-Reyes M, Owens SM. Kinetic Study of Smoking Marijuana. J Pharmacokinet Biopharm 1982:10:495–506.CrossRefPubMedGoogle Scholar
  39. 39.
    Fadiman J.Genista canariensis: a Minor Psychedelic. Econ Botany 1965:19:383.Google Scholar
  40. 40.
    Wink M, Witte L, Hartmann T, Theuring C, Volz V. Accumulation of Quinolizidine Alkaloids in Plants and Cell Suspension Cultures: GeneraLupinus, Cytisus, Baptisia, Genista, Laburnum, andSophora. Planta Med 1983:48:253–7.Google Scholar
  41. 41.
    Barlow RB, McLeod LJ. Some studies on cytisine and its methylated derivatives. Br J Pharmacol 1969:35:161–74.PubMedGoogle Scholar
  42. 42.
    Zachowski J. Zur Pharmakologie des Cytisins. Naunyn Schmiedebergs Arch Pharmacol 1938;189:327–44.Google Scholar
  43. 43.
    Litzinger WJ. Ceramic evidence for prehistoricDatura use in North America. J Ethnopharmacol 1981:4:57–74.CrossRefPubMedGoogle Scholar
  44. 44.
    Porter MN. Pipas Precortesianas. México, 1948.Google Scholar
  45. 45.
    Reko VA. Magische Gifte, Rausch- und Betäubungsmittel der Neuen Welt. 3rd ed. Stuttgart: Ferdinand Enke Verlag, 1949.Google Scholar
  46. 46.
    Hegnauer R. Chemotaxonomie der Pflanzen — Eine Übersicht über die Verbreitung und die systematische Bedeutung der Pflanzenstoffe. Band 6. Dicotyledoneae: Rafflesiaceae-Zygophyllaceae. Basel: Birkhäuser Verlag, 1973.Google Scholar
  47. 47.
    Siegel RK. Herbal Intoxication — Psychoactive Effects from Herbal Cigarettes, Tea, and Capsules. JAMA 1976;236:473–6.CrossRefPubMedGoogle Scholar
  48. 48.
    Wilcox Jr WP. More cases of atropinism. N Engl J Med 1967;277:1209.Google Scholar
  49. 49.
    Bühler A. De coca bij de Indianen van Zuid-Amerika. Ciba-Tijdschrift 1948;(32): 1066–79.Google Scholar
  50. 50.
    Jeri FR, Sanchez C, Del Pozo T, Fernandez M. The Syndrome of Coca Paste. J Psychedelic Drugs 1978:10:361–70.Google Scholar
  51. 51.
    Rivier L. Analysis of alkaloids in leaves of cultivatedErythroxylum and characterization of alkaline substances used during coca chewing. J Ethnopharmacol 1981:3:313–35.PubMedGoogle Scholar
  52. 52.
    Grinspoon L, Bakalar JB. Cocaine — A drug and its social evolution. New York: Basic Books, Inc., 1976.Google Scholar
  53. 53.
    Paly D, Jatlow P, Van Dyke C, Jeri FR, Byck R. Plasma cocaine concentrations during cocaine paste smoking. Life Sci 1982:30:731–8.CrossRefPubMedGoogle Scholar
  54. 54.
    Perez-Reyes M, DiGuiseppi S, Ondrusek G, Jeffcoat AR, Cook CE. Free-base cocaine smoking. Clin Pharmacol Ther 1982:32:459–65.PubMedGoogle Scholar
  55. 55.
    Mariani Ramírez C. Temas de Hipnosis. Santiago: Editorial Andres Bello, 1965.Google Scholar
  56. 56.
    Kaczmarek F, Steinegger E. Untersuchung der Alkaloide vonLobelia tupa L. Pharm Acta Helv 1958;33:257–62.PubMedGoogle Scholar
  57. 57.
    Rosecrans JA, Spencer RM, Krynock GM, Chance WT. Discriminative Stimulus Properties of Nicotine and Nicotine-related Compounds. In: Bättig K, ed. Behavioral Effects of Nicotine. International Workshop on Behavioral Effects of Nicotine, Zürich, September 1976. Basel: S. Karger. 1978:70–82.Google Scholar
  58. 58.
    Taylor P. Ganglionic Stimulating and Blocking Agents. In: Gilman AG. Goodman LS, Gilman A, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 6th ed. New York: Macmillan Publishing Co., 1980:211–9.Google Scholar
  59. 59.
    McLaren G. Sudden death in asthma. Br Med J 1968;4:456.PubMedGoogle Scholar
  60. 60.
    Robicsek F. The Smoking Gods. Tobacco in Maya Art, History and Religion. Norman: University of Oklahoma Press, 1978.Google Scholar
  61. 61.
    Wilbert J. Magico-religious use of tobacco among South American Indians. In: Rubin V, ed. Cannabis and Culture. The Hague: Mouton, 1975:439–62.Google Scholar
  62. 62.
    Benowitz NL, Hall SM, Herning RI, Jacob III P, Jones RT, Osman A-L. Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med 1983;309:139–42.PubMedGoogle Scholar
  63. 63.
    Benowitz NL, Kuyt F, Jacob III P. Circadian blood nicotine concentrations during cigarette smoking. Clin Pharmacol Ther 1982;32:758–64.PubMedGoogle Scholar
  64. 64.
    De Sahagún B. Florentine Codex — General History of the Things of New Spain. Part XI: Book 10. The People. (Translated by Dibble CE and Anderson AJO.) Santa Fe: School of American Research and University of Utah, 1961.Google Scholar
  65. 65.
    De Sahagún B. Florentine Codex — General History of the Things of New Spain. Part XII: Book 11. Earthly Things. (Translated by Dibble CE and Anderson AJO.) Santa Fe: School of American Research and University of Utah, 1963.Google Scholar
  66. 66.
    Martínez M. Catálogo de nombres vulgares y científicas de plantas mexicanas. México: Fondo de cultura económica, 1979.Google Scholar
  67. 67.
    Wasson RG. The Wondrous Mushroom — Mycolatry in Mesoamerica. New York: McGraw-Hill Book Company, 1980.Google Scholar
  68. 68.
    Raffauf RF, Zennie TM, Onan KD, Le Quesne PW. Funebrine, a Structurally Novel Pyrrole Alkaloid, and Other γ-Hydroxyisoleucine-related Metabolites ofQuararibea funebris (Llave) Vischer (Bombacaceae). J Org Chem 1984:49:2714–8.CrossRefGoogle Scholar
  69. 69.
    Siegel RK, Ceilings PR, Díaz JL. On the Use ofTagetes lucida andNicotiana rustica as a Huichol Smoking Mixture: the Aztec ‘Yahutli’ with Suggestive Hallucinogenic Effects. Econ Botany 1977;31:16–23.Google Scholar
  70. 70.
    Chan GFQ, Lee MM, Glushka J, Towers GHN. Photosensitizing thiophenes inPorophyllum, Tessaria andTagetes. Phytochemistry 1979:18:1566.CrossRefGoogle Scholar
  71. 71.
    Sharon DG, Donnan CB. The Magic Cactus — Ethnoarchaeological Continuity in Peru. Archaeology 1977;30:374–81.Google Scholar
  72. 72.
    Crosby DM, McLaughlin JL. Cactus Alkaloids. XIX. Crystallization of Mescaline HCI and 3-Methoxytyramine HCI fromTrichocereus pachanoi. Lloydia 1973:36:416–8.PubMedGoogle Scholar
  73. 73.
    Giberti GC. MedicinalMutisieae (Compositae) of Northwestern Argentina, a Contribution to their Identification. In: Notes from the Jodrell Laboratory. 9. Kew: Royal Botanical Gardens, 1981:1–44.Google Scholar
  74. 74.
    Zardini EM. The identification of an Argentinan narcotic. In: Botanical Museum Leaflets, 25. Boston: Harvard University 1977:105–7.Google Scholar
  75. 75.
    Miyakado M, Ohno N, Yoshioka H, Mabry TJ. Trichoclin, a new furocoumarin fromTrichocline incana. Phytochemistry 1978:17:143–4.CrossRefGoogle Scholar
  76. 76.
    Corothie E, Nakano T. Constituents of the bark ofVirola sebifera. Planta Med 1969;17:184–8.PubMedGoogle Scholar
  77. 77.
    McKenna DJ, Towers GHN, Abbott F. Monoamine oxidase inhibitors in South American hallucinogenic plants — part 2: constituents of orally active myristica- ceous hallucinogens. J Ethnopharmacol 1984:12:179–211.CrossRefPubMedGoogle Scholar
  78. 78.
    Díaz JL. Etnofarmacología de algunos psicotrópicos vegetales de México. In: Díaz JL, ed. Etnofarmacología de Plantas Alucinógenas Latinoamericanas. Cuaderno Científico Cemef no. 4. México: Centro Mexicano de Estudios en Farmacodependencia, 1976:135–201.Google Scholar
  79. 79.
    Schulze RG. Nutmeg as a hallucinogen. N Engl J Med 1976;295:174.PubMedGoogle Scholar
  80. 80.
    Pollock SH. The Psilocybin Mushroom Pandemic. J Psychedelic Drugs 1975:7:73–84.Google Scholar

Copyright information

© Bohn, Scheltema & Holkema 1985

Authors and Affiliations

  • P. A. G. M. De Smet
    • 1
  1. 1.Royal Dutch Association for Advancement of PharmacyJL The HagueThe Netherlands

Personalised recommendations